Ra Research Program

* { display:table-row; vertical-align:top; } .team div > * { display:table-cell; vertical-align:top; width:auto; } .team img { margin:0px; width:150px; margin-inline-end:10px; margin-block-end:10px; } /*-->*/ /*-->*/
Dr. Ra

Chaelin “Karen” Ra, PhD, MPH
Instructor of Medicine

Clinical Research

The Rutgers Cancer Institute Clinical Research Program is organized based on disease teams, mainly related to specific diagnoses. Some of the Disease Specific Groups are more thematic: Early Drug Development (Phase 1), Precision Medicine, and Cellular Therapies. Each disease team reviews available clinical trials or develops their own trials to meet the clinical needs of patients within their area of expertise (for example, breast cancer) at Rutgers Cancer Institute and RWJBarnabas Health sites for all patients across the system.